Quality or speed? Scientists face Covid-19 dilemma There was a heated debate in parliament about whether only Martin Ackermann, president of the National Covid-19 Science Taskforce, should be allowed to speak publicly about Covid-19. In the end parliament decided against this. Keystone / Peter Schneider The Covid-19 pandemic has pushed science and research to the fore. But the unprecedented influence it currently wields over politics and public life has a downside: the crisis demands quick answers that risk scientists’ credibility. This content was published on April 29, 2021 - 09:00 April 29, 2021 - 09:00 Christian Raaflaub “Since the start of the pandemic there has been a veritable tsunami of scientific publications about Sars-CoV-2,” says Subhra Priyadarshini, editor-in-chief of